Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse
Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse
Active, not recruiting · NCT04475731 · Registry updated 2024-10-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 2 | 2024-10-22 | NCT04475731 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 40 |
22 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.